According to Yu et al., DLT ameliorated SA-AKI by inhibiting the poly (ADP-ribose) polymerase-1/high-mobility group box 1 (PARP1/HMGB1) pathway, which plays a role in the inflammatory response [95,96,97]. Here, HMGB1 is linked to acute kidney injury.